• top_image

Metformin may increase ovarian cancer survival

December 21, 2012

A retrospective, case-control study at Mayo Clinic, found the diabetes drug metformin may increase survival in women with ovarian cancer. It reported that ovarian cancer patients with diabetes taking metformin during treatment had a 4 times greater 5-year survival rate, compared to non-diabetic ovarian cancer patients not taking the drug. <link href="http://www.ncbi.nlm.nih.gov/pubmed/22183212">Abstract here</link>.

Back